165 related articles for article (PubMed ID: 20446602)
21. Results of resection of T3 non-small cell lung cancer invading the mediastinum or main bronchus.
Pitz CC; Brutel de la Rivière A; Elbers HR; Westermann CJ; van den Bosch JM
Ann Thorac Surg; 1996 Oct; 62(4):1016-20. PubMed ID: 8823082
[TBL] [Abstract][Full Text] [Related]
22. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
[TBL] [Abstract][Full Text] [Related]
23. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
Huang GJ; Fang DK; Cheng GY; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
[TBL] [Abstract][Full Text] [Related]
24. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
25. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
26. [Results of resection of T3N0-2M0 non-small cell lung cancer according to involved organ and nodal status].
Oda M; Watanabe S; Tsukayama S; Tomita Y; Ohta Y; Murakami S; Watanabe Y
Kyobu Geka; 1998 Oct; 51(11):902-6. PubMed ID: 9789416
[TBL] [Abstract][Full Text] [Related]
27. The prognostic impact of main bronchial lymph node involvement in non-small cell lung carcinoma: suggestions for a modification of the staging system.
Shimada Y; Tsuboi M; Saji H; Miyajima K; Usuda J; Uchida O; Kajiwara N; Ohira T; Hirano T; Kato H; Ikeda N
Ann Thorac Surg; 2009 Nov; 88(5):1583-8. PubMed ID: 19853116
[TBL] [Abstract][Full Text] [Related]
28. Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer.
Watanabe S; Asamura H; Suzuki K; Tsuchiya R
Ann Thorac Surg; 2005 May; 79(5):1682-5. PubMed ID: 15854954
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
[TBL] [Abstract][Full Text] [Related]
30. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
Pezzetta E; Stupp R; Zouhair A; Guillou L; Taffé P; von Briel C; Krueger T; Ris HB
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1092-8. PubMed ID: 15896624
[TBL] [Abstract][Full Text] [Related]
31. [Results of surgical treatment in patients with T3 non-small cell lung cancer].
Aoki T; Yamato Y; Souma T; Yoshiya K; Tsuchida M; Watanabe T; Hashimoto T; Shinohara H; Hayashi J
Kyobu Geka; 1998 Oct; 51(11):921-5. PubMed ID: 9789420
[TBL] [Abstract][Full Text] [Related]
32. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
33. [The significance of surgical treatment for T4 lung cancer].
Sakurada A; Sagawa M; Usuda K; Kanda A; Aikawa H; Chen Y; Endo O; Takahashi H; Takahashi S; Sato M; Saito Y; Fujimura S
Kyobu Geka; 1997 Feb; 50(2):95-100. PubMed ID: 9028064
[TBL] [Abstract][Full Text] [Related]
34. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
35. Surgical therapy for carcinoma of the lung.
Shields TW
Clin Chest Med; 1993 Mar; 14(1):121-47. PubMed ID: 8384959
[TBL] [Abstract][Full Text] [Related]
36. [Significance of pulmonary lymph node metastases in locally advanced non-small cell lung cancer].
Marra A; Hillejan L; Pöttgen C; Zaboura G; Fechner S; Greschuchna D; Stamatis G
Pneumologie; 2002 Dec; 56(12):773-80. PubMed ID: 12486615
[TBL] [Abstract][Full Text] [Related]
37. Chest wall invasion in non-small cell lung carcinoma: a rationale for en bloc resection.
Facciolo F; Cardillo G; Lopergolo M; Pallone G; Sera F; Martelli M
J Thorac Cardiovasc Surg; 2001 Apr; 121(4):649-56. PubMed ID: 11279404
[TBL] [Abstract][Full Text] [Related]
38. Results of surgical treatment in patients with stage IIIB non-small-cell lung cancer.
Watanabe Y; Shimizu J; Oda M; Hayashi Y; Tatsuzawa Y; Watanabe S; Urayama H; Iwa T
Thorac Cardiovasc Surg; 1991 Feb; 39(1):50-4. PubMed ID: 1849325
[TBL] [Abstract][Full Text] [Related]
39. Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy.
Kim YT; Kang CH; Sung SW; Kim JH
Ann Thorac Surg; 2005 Apr; 79(4):1153-61; discussion 1153-61. PubMed ID: 15797043
[TBL] [Abstract][Full Text] [Related]
40. Chest wall invasion in carcinoma of the lung. Therapeutic and prognostic implications.
McCaughan BC; Martini N; Bains MS; McCormack PM
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):836-41. PubMed ID: 2987619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
